The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy.

Topkan, Erkan; Selek, Ugur; Pehlivan, Berrin; Kucuk, Ahmet; Haksoyler, Veysel; Kilic Durankus, Nulifer; Sezen, Duygu; Bolukbasi, Yasemin

Topkan, Erkan; Selek, Ugur; Pehlivan, Berrin; Kucuk, Ahmet; Haksoyler, Veysel; Kilic Durankus, Nulifer; Sezen, Duygu; Bolukbasi, Yasemin.

Afiliación

Topkan E; Department of Radiation Oncology, Baskent University Medical Faculty, Adana, Turkey.
Selek U; Department of Radiation Oncology, Koc University Faculty of Medicine, Istanbul, Turkey.
Pehlivan B; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kucuk A; Department of Radiation Oncology, Bahcesehir University, Istanbul, Turkey.
Haksoyler V; Radiation Oncology Clinics, Mersin City Hospital, Mersin, Turkey.
Kilic Durankus N; Clinics of Medical Oncology, Medline Hospital, Adana, Turkey.
Sezen D; Department of Radiation Oncology, Koc University Faculty of Medicine, Istanbul, Turkey.
Bolukbasi Y; Department of Radiation Oncology, Koc University Faculty of Medicine, Istanbul, Turkey.

J Inflamm Res ; 14: 4433-4444, 2021.

Article en En | MEDLINE | ID: mdl-34511977

Palabras clave

concurrent chemoradiotherapy; locally advanced pancreas cancer; pancreas cancer prognostic index; prognosis; survival outcomes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Inflamm Res Año: 2021 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google